federal_register: 2021-27825
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-27825 | Technical Considerations for Medical Devices With Physiologic Closed-Loop Control Technology; Draft Guidance for Industry and Food and Drug Administration Staff; Availability | Notice | The Food and Drug Administration (FDA or Agency) is announcing the availability of the draft guidance entitled "Technical Considerations for Medical Devices with Physiologic Closed-Loop Control Technology." Physiologic Closed-Loop Control (PCLC) devices are intended for automatic control of a physiologic variable(s) through delivery of energy or substance using feedback from physiologic sensors. PCLC devices may play an important role in reducing cognitive overload, minimizing human error, and enhancing medical care during emergency response and medical surge situations. This draft guidance provides technical considerations for PCLC technology in order to promote development and availability of safe and effective PCLC medical devices. This draft guidance is not final nor is it in effect at this time. | 2021-12-23 | 2021 | 12 | https://www.federalregister.gov/documents/2021/12/23/2021-27825/technical-considerations-for-medical-devices-with-physiologic-closed-loop-control-technology-draft | https://www.govinfo.gov/content/pkg/FR-2021-12-23/pdf/2021-27825.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA or Agency) is announcing the availability of the draft guidance entitled "Technical Considerations for Medical Devices with Physiologic Closed-Loop Control Technology." Physiologic Closed-Loop Control (PCLC)... |